Global Hepatocyte Growth Factor Market by Manufacturers, Countries, Type and Application, Forecast to 2023

February 2018 | 108 pages | ID: GD9D27B6520EN
GlobalInfoResearch

Abstracts

Hepatocyte growth factor (HGF) (or scatter factor (SF) is a paracrine cellular growth, motility and morphogenic factor. It is secreted by mesenchymal cells and targets and acts primarily upon epithelial cells and endothelial cells, but also acts on haemopoietic progenitor cells and T cells. It has been shown to have a major role in embryonic organ development, specifically in myogenesis, in adult organ regeneration, and in wound healing.

Scope of the Report:

This report focuses on the Hepatocyte Growth Factor in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Market Segment by Manufacturers, this report covers

• ViroMed
• AnGes MG
• M3 Biotechnology
• AVEO Pharmaceuticals
• Molecular Partners
• Yooyoung Pharm
• F-star
• Galaxy Biotech
• Kringle Pharma

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, coversMarket Segment by Applications, can be divided into

• Oncology
• Cardiovascular
• Central Nervous System
• Hematological Disorders
• Others

There are 15 Chapters to deeply display the global Hepatocyte Growth Factor market.

Chapter 1, to describe Hepatocyte Growth Factor Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Hepatocyte Growth Factor, with sales, revenue, and price of Hepatocyte Growth Factor, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Hepatocyte Growth Factor, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Hepatocyte Growth Factor market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Hepatocyte Growth Factor sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Hepatocyte Growth Factor Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
  1.3.1 Oncology
  1.3.2 Cardiovascular
  1.3.3 Central Nervous System
  1.3.4 Hematological Disorders
  1.3.5 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market Status and Outlook (2013-2023)
    1.4.1.2 Canada Market Status and Outlook (2013-2023)
    1.4.1.3 Mexico Market Status and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market Status and Outlook (2013-2023)
    1.4.2.2 France Market Status and Outlook (2013-2023)
    1.4.2.3 UK Market Status and Outlook (2013-2023)
    1.4.2.4 Russia Market Status and Outlook (2013-2023)
    1.4.2.5 Italy Market Status and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market Status and Outlook (2013-2023)
    1.4.3.2 Japan Market Status and Outlook (2013-2023)
    1.4.3.3 Korea Market Status and Outlook (2013-2023)
    1.4.3.4 India Market Status and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market Status and Outlook (2013-2023)
    1.4.4.2 Egypt Market Status and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
    1.4.4.4 South Africa Market Status and Outlook (2013-2023)
    1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 ViroMed
  2.1.1 Business Overview
  2.1.2 Hepatocyte Growth Factor Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 ViroMed Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 AnGes MG
  2.2.1 Business Overview
  2.2.2 Hepatocyte Growth Factor Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 AnGes MG Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 M3 Biotechnology
  2.3.1 Business Overview
  2.3.2 Hepatocyte Growth Factor Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 M3 Biotechnology Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 AVEO Pharmaceuticals
  2.4.1 Business Overview
  2.4.2 Hepatocyte Growth Factor Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 AVEO Pharmaceuticals Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Molecular Partners
  2.5.1 Business Overview
  2.5.2 Hepatocyte Growth Factor Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Molecular Partners Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Yooyoung Pharm
  2.6.1 Business Overview
  2.6.2 Hepatocyte Growth Factor Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Yooyoung Pharm Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 F-star
  2.7.1 Business Overview
  2.7.2 Hepatocyte Growth Factor Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 F-star Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Galaxy Biotech
  2.8.1 Business Overview
  2.8.2 Hepatocyte Growth Factor Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Galaxy Biotech Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Kringle Pharma
  2.9.1 Business Overview
  2.9.2 Hepatocyte Growth Factor Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Kringle Pharma Hepatocyte Growth Factor Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL HEPATOCYTE GROWTH FACTOR SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Hepatocyte Growth Factor Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hepatocyte Growth Factor Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Hepatocyte Growth Factor Manufacturer Market Share
  3.3.2 Top 6 Hepatocyte Growth Factor Manufacturer Market Share
3.4 Market Competition Trend

4 GLOBAL HEPATOCYTE GROWTH FACTOR MARKET ANALYSIS BY REGIONS

4.1 Global Hepatocyte Growth Factor Sales, Revenue and Market Share by Regions
  4.1.1 Global Hepatocyte Growth Factor Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Hepatocyte Growth Factor Revenue and Market Share by Regions (2013-2018)
4.2 North America Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
4.3 Europe Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
4.5 South America Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)

5 NORTH AMERICA HEPATOCYTE GROWTH FACTOR BY COUNTRIES

5.1 North America Hepatocyte Growth Factor Sales, Revenue and Market Share by Countries
  5.1.1 North America Hepatocyte Growth Factor Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Hepatocyte Growth Factor Revenue and Market Share by Countries (2013-2018)
5.2 United States Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
5.3 Canada Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
5.4 Mexico Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)

6 EUROPE HEPATOCYTE GROWTH FACTOR BY COUNTRIES

6.1 Europe Hepatocyte Growth Factor Sales, Revenue and Market Share by Countries
  6.1.1 Europe Hepatocyte Growth Factor Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Hepatocyte Growth Factor Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
6.3 UK Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
6.4 France Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
6.5 Russia Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
6.6 Italy Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC HEPATOCYTE GROWTH FACTOR BY COUNTRIES

7.1 Asia-Pacific Hepatocyte Growth Factor Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Hepatocyte Growth Factor Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Hepatocyte Growth Factor Revenue and Market Share by Countries (2013-2018)
7.2 China Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
7.3 Japan Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
7.4 Korea Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
7.5 India Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA HEPATOCYTE GROWTH FACTOR BY COUNTRIES

8.1 South America Hepatocyte Growth Factor Sales, Revenue and Market Share by Countries
  8.1.1 South America Hepatocyte Growth Factor Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Hepatocyte Growth Factor Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
8.3 Argentina Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
8.4 Colombia Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA HEPATOCYTE GROWTH FACTOR BY COUNTRIES

9.1 Middle East and Africa Hepatocyte Growth Factor Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Hepatocyte Growth Factor Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Hepatocyte Growth Factor Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
9.3 UAE Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
9.4 Egypt Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
9.5 Nigeria Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)
9.6 South Africa Hepatocyte Growth Factor Sales and Growth Rate (2013-2018)

10 GLOBAL HEPATOCYTE GROWTH FACTOR MARKET SEGMENT BY TYPE

10.1 Global Hepatocyte Growth Factor Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Hepatocyte Growth Factor Sales and Market Share by Type (2013-2018)
  10.1.2 Global Hepatocyte Growth Factor Revenue and Market Share by Type (2013-2018)

11 GLOBAL HEPATOCYTE GROWTH FACTOR MARKET SEGMENT BY APPLICATION

11.1 Global Hepatocyte Growth Factor Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Cardiovascular Sales Growth (2013-2018)
11.4 Central Nervous System Sales Growth (2013-2018)
11.5 Hematological Disorders Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)

12 HEPATOCYTE GROWTH FACTOR MARKET FORECAST (2018-2023)

12.1 Global Hepatocyte Growth Factor Sales, Revenue and Growth Rate (2018-2023)
12.2 Hepatocyte Growth Factor Market Forecast by Regions (2018-2023)
  12.2.1 North America Hepatocyte Growth Factor Market Forecast (2018-2023)
  12.2.2 Europe Hepatocyte Growth Factor Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Hepatocyte Growth Factor Market Forecast (2018-2023)
  12.2.4 South America Hepatocyte Growth Factor Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Hepatocyte Growth Factor Market Forecast (2018-2023)
12.3 Hepatocyte Growth Factor Market Forecast by Type (2018-2023)
  12.3.1 Global Hepatocyte Growth Factor Sales Forecast by Type (2018-2023)
  12.3.2 Global Hepatocyte Growth Factor Market Share Forecast by Type (2018-2023)
12.4 Hepatocyte Growth Factor Market Forecast by Application (2018-2023)
  12.4.1 Global Hepatocyte Growth Factor Sales Forecast by Application (2018-2023)
  12.4.2 Global Hepatocyte Growth Factor Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source@LOT

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hepatocyte Growth Factor Picture
Table Product Specifications of Hepatocyte Growth Factor
Figure Global Sales Market Share of Hepatocyte Growth Factor by Types in 2017
Table Hepatocyte Gro